The company estimates that about six million people annually in the United States, primarily children, are affected by the condition which previously had no approved treatments.
Tag Archive for: viral skin disease
After making a splash with the full approval of Eisai and Biogen’s Leqembi (lecanemab) on July 6, the FDA has just three scheduled target action dates coming up in the next two weeks; two for cancer and one for a viral skin disease.